Eckert & Ziegler SE (0NZY.IL)
IOB · EUR · Healthcare · Medical Devices
€12.97 (-1.48%) as of
Key statistics
- Market cap
- 269.94M
- P/E (TTM)
- 10.54
- EPS (TTM)
- 1.23
- Dividend yield
- 1.51%
- 52-week range
- 11.98 – 17.40
- Beta
- 1.39
- Revenue (TTM)
- 232.83M
- Profit margin
- 11.06%
- Volume
- 763.00
About Eckert & Ziegler SE
Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide. It operates in two segments, Medical and Isotope Products. The Medical segment offers small radioactive implants for the treatment of prostate cancer seeds; and eye application based on ruthenium-106 or iodine-125 for treating uveal melanoma. This segment also provides radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, and other consumables. The Isotope Products segment manufactures and sells standard and radiation sources for medical and industrial sectors. This segment offers calibration related sources for radioisotopes. Eckert & Ziegler Strahlen- und Medizintechnik AG was founded in 1992 and is based in Berlin, Germany.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Berlin, Germany
- Employees
- 1,036
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.